Subcutaneous Lavage in Cesarean Section
Antiseptic Washing Prior to Skin Closure During Cesarean Delivery- a Randomized Control Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
The goal of this clinical trial is to learn if antiseptic washing prior to skin closure during cesarean section reduces rates of surgical site infection. intraoperative washing is a common practice in other surgical fields and several studies have shown efficacy in reducing postoperative infection rates. no randomized control trial has tested this intervention during cesarean section. The main questions we aim to answer are: Does subcutaneous antiseptic washing reduce the rates of surgical site infection? Does antiseptic washing improve scar healing? Does antiseptic washing reduce hospital stay, postpartum fever rates and readmission cases? Researchers will compare subcutaneous antiseptic washing to no intervention to see if surgical site infection rates reduce Participants will: consent to participate in the trial Visit the postpartum clinic 30 days after surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
June 12, 2024
CompletedStudy Start
First participant enrolled
September 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 19, 2025
May 1, 2024
3 years
May 7, 2024
March 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
surgical site infection
SSI infection rates
30 days after surgery
Secondary Outcomes (3)
hospital stay
30 days after surgery
wound healing
30 days after surgery
postpartum fever
30 days after surgery
Study Arms (2)
Subcutan lavage
ACTIVE COMPARATORSubcutaneous washing with antiseptic solution: Chlorhexidine gluconate 0.2%
no lavage
PLACEBO COMPARATORNo subcutaneous washing
Interventions
subcutaneous washing with chlorhexidine gluconate prior to skin closure
Eligibility Criteria
You may qualify if:
- pregnant women undergoing cesarean delivery
You may not qualify if:
- pregnant women undergoing vaginal delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2024
First Posted
June 12, 2024
Study Start
September 22, 2024
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
March 19, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share